Christopher Collins, MD, is an attending rheumatologist and program director of the Rheumatology Division, MedStar Washington Hospital Center, and an assistant professor of Medicine, Georgetown University Medical Center.

At the Hospital Center, he works in the lupus clinic and serves as director for the Rheumatology fellowship program. His practice is focused on systemic lupus erythematosus, rheumatoid arthritis and connective tissue diseases. He is actively engaged in clinical research, including studies of various rheumatic diseases as well as medical education. Prior to joining the Hospital Center, Dr. Collins was a senior research fellow at the National Institute for Arthritis and Musculoskeletal and Skin Diseases (NIAMS), where he performed clinical investigations in lupus.

Dr. Collins has been awarded multiple honors at the local and national levels, including the Distinguished Fellow Award and Clinician Scholar Educator Award from the American College of Rheumatology (ACR). Dr. Collins is a member of several additional medical societies, including the American College of Physicians, the American Medical Association and the Lupus Foundation of America.

He serves on the ACR’s Subcommittee on Medical Student and Resident Education and its Test Material Development Committee. He is a member of the Medical and Scientific Advisory Council for the Lupus Foundation of Greater Washington. His research has been published in peer-reviewed journals, includingRheumatology International and Arthritis Research and Therapy. Dr. Collins is certified by the American Board of Internal Medicine in Internal Medicine and Rheumatology.

His medical degree is from the University of Arkansas for Medical Sciences. Dr. Collins completed a residency in Internal Medicine at the University of Southern California in Los Angeles, where he also completed a fellowship in Rheumatology. He then completed a Rheumatology Research fellowship at the National Institutes of Health/ NIAMS.

Research Interests

Dr. Collins’ research interests include

  • Systemic lupus erythematosus
  • Rheumatoid arthritis
  • Connective tissue diseases
  • Medical education

Selected Research

Calcium and Vitamin D Supplementation and Rheumatoid Arthritis: the Women's Health Initiative Calcium Plus Vitamin D Trial

Dr. Collins participated in this Women’s Health Initiative trial sponsored by the National Institutes of Health. This research was conducted to determine whether calcium plus vitamin D supplementation affects incidence of rheumatoid arthritis. The results of this trial were published in Rheumatology International (2012;32:3823-3830).

Evaluation of BIIB023 for Patients With Lupus Nephritis

Dr. Collins is a principal investigator on this randomized, double-blind Phase 2 trial (Anti-Tweak in Lupus Nephritis Patients [ATLAS]) sponsored by Biogen Idec. This study will assess the efficacy of BIIB023 as an add-on treatment for patients with systemic lupus erythematosus.

Efficacy and Safety of Belimumab in Black Adults With Systemic Lupus Erythematosus (EMBRACE)

Dr. Collins is a principal investigator for these Phase 3 and 4 trials, sponsored by Human Genome Sciences Inc., a GlaxoSmithKline Company. These studies are designed to evaluate the efficacy, safety, and tolerability of belimumab in black patients with systemic lupus erythematosus.

Evaluation of use of belimumab in clinical practice settings (ENABLE)

Dr. Collins is a co-principal investigator on this trial, sponsored by Human Genome Sciences Inc., a GlaxoSmithKline Company.

View Dr. Collins' publications on PubMed

Research Areas

  • Other Medical